middle.news
How Recce’s A$8.4M Raise Fuels Its Fight Against Superbugs
2:22am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
How Recce’s A$8.4M Raise Fuels Its Fight Against Superbugs
2:22am on Monday 2nd of June, 2025 AEST
Key Points
Raised A$3.4 million from existing shareholders via 1-for-6 entitlement offer
Total capital raised reaches A$8.4 million including prior A$5 million placement
Funds earmarked for Phase 3 registrational trials in Indonesia and Australia
Entitlement offer shortfall of 26.37 million shares may be placed by August 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Recce Pharmaceuticals (ASX:RCE)
OPEN ARTICLE